Laboratory markers in IBD: useful, magic, or unnecessary toys? - Wikidata - wikimedia - TriplyDB

Laboratory markers in IBD: useful, magic, or unnecessary toys?

Laboratory markers in IBD: useful, magic, or unnecessary toys?

http://www.wikidata.org/entity/Q36394876

about

Mean platelet volume: a controversial marker of disease activity in Crohn’s disease Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis Disease monitoring in inflammatory bowel disease Markers of bacterial translocation in end-stage liver disease Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis Optimising monitoring in the management of Crohn's disease: a physician's perspective Laboratory markers in ulcerative colitis: Current insights and future advances Diagnostic accuracy of fecal lactoferrin for inflammatory bowel disease: a meta-analysis Current application of proteomics in biomarker discovery for inflammatory bowel disease Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives The analysis of factors associated with progression of isolated terminal ileal lesions Genome-wide maps of circulating miRNA biomarkers for ulcerative colitis Limitations in assessment of mucosal healing in inflammatory bowel disease Potential urinary biomarkers of disease activity in Crohn's disease.Capsule endoscopy: High negative predictive value in the long term despite a low diagnostic yield in patients with suspected Crohn's disease.Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome Biomarkers of inflammatory bowel disease.Dietary and metabolomic determinants of relapse in ulcerative colitis patients: A pilot prospective cohort study.Physician global assessments or blood tests do not predict mucosal healing in ulcerative colitis Optimal diagnosis and disease activity monitoring of intestinal Behçet's disease Correlation between soluble triggering receptor expressed on myeloid cells-1 and endoscopic activity in intestinal Behçet's disease.Serum calprotectin levels correlate with biochemical and histological markers of disease activity in TNBS colitis Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases.Can chronic gastritis cause an increase in fecal calprotectin concentrations?Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel disease: a pilot study.Assessment of causal link between psychological factors and symptom exacerbation in inflammatory bowel disease: a protocol for systematic review of prospective cohort studies Serum beta 2-microglobulin as a biomarker in inflammatory bowel disease New proteomic approaches for biomarker discovery in inflammatory bowel disease.The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies.Clinical pharmacology of AMG 181, a gut-specific human anti-α4β7 monoclonal antibody, for treating inflammatory bowel diseases.S100A expression and interleukin-10 polymorphisms are associated with ulcerative colitis and diarrhea predominant irritable bowel syndrome.Soluble ST2: a new and promising activity marker in ulcerative colitis.Serum glycan markers for evaluation of disease activity and prediction of clinical course in patients with ulcerative colitis.Gene expression analysis of peripheral cells for subclassification of pediatric inflammatory bowel disease in remission.A new model for the discrimination between ulcerative colitis and Crohn's disease Is moderate red wine consumption safe in inactive inflammatory bowel disease?Genes of intestinal Escherichia coli and their relation to the inflammatory activity in patients with ulcerative colitis and Crohn's disease.Correlation between triggering receptor expressed on myeloid cells-1 and clinical disease activity in Chinese patients with ulcerative colitis.

P2860

Q21195814-749DC0C9-4CAE-47E1-AD1D-3264AB3886B0 Q24608254-A95B6B22-2CF6-4C5A-977F-B85ABD090710 Q26777553-3710C4A2-F99F-4804-9D6D-2C58AD84D46D Q26783888-9EAAAA28-B263-4DDC-A2E0-EA33539EF3CF Q26996550-C97F42FC-19A2-468C-8A28-78131972488E Q27007083-47F17B40-7C0C-4CC9-960E-08781575427C Q27027022-13DAA066-611F-4B4E-BA13-894A24B51705 Q28066449-8564CB98-8A80-4F39-8317-E8CB8E26BD6E Q28078755-0FC89D0F-D6F9-48E5-ABF6-04032789BD6C Q28085134-34A37528-42C7-4484-B5DC-3B97DC23C501 Q28540843-FFF34488-5D55-4F03-AFFC-54008B7F3BD9 Q28732042-564E237D-BAC5-47E6-8923-A1E5CC6BD948 Q33564957-DDA630B4-2030-4F63-9D4F-8664F351AB66 Q33638861-48BE6E40-A093-43E8-A552-7821364DA1FD Q33695305-1DC8023B-BB45-4007-87FA-0CF666AE8495 Q33696448-804EC403-1EB3-44E5-BE88-8CFADF47E3FB Q33718699-7F32CC59-BE84-40CA-96AB-9D8FD82D5D9C Q33746983-FDFD922A-BB9F-47F5-81CA-44AD32B8FF80 Q33786052-3686B821-7522-4229-AF7B-E0C23181C71F Q33810986-8F501C28-FC7C-479F-89E9-5152F816B3A1 Q33819484-CA7B68AD-AD9E-4EAB-9D98-F21E8215C1D1 Q33822597-43F07E1D-725B-428F-9A7B-035235B5484B Q33840425-CA217449-6685-4AE8-A1E8-F2F993B65E69 Q33857049-1A90B336-453E-4F3F-BD11-66EA232BB349 Q33998635-52B41CC1-5946-4199-B30F-654F2DE657E9 Q34021834-419D6EAA-6D28-4158-A775-8F93E8989A76 Q34035245-9054E817-71D4-4EB7-8F0D-3D05A5041D17 Q34067914-51156BC6-DDE9-46F5-8D4E-FCFA9FDEE76F Q34096526-1DDDA6F1-EA7D-4B54-A898-E635A19647D9 Q34147687-F96430B2-2E66-4A93-BDA5-E3B58B900E58 Q34413480-C3456CFA-CDBB-48F5-BC11-9A643344821C Q34635522-228D7E3E-DA56-4A17-8DEC-2958B13136E7 Q34675807-41CA606F-1594-4BE3-BEBA-B0AA42F1CC4C Q34975712-7A979FEE-B6E9-4312-9D92-592C03A978A8 Q35014345-25B00E60-07AF-4755-9757-A3E8F58FEC6D Q35048529-5B4323CB-C9F3-4D1E-8FAB-BB3728D49B7B Q35173628-18BC6E4C-A0EA-4E41-9041-2AD0F6FED1D8 Q35233663-020D8D57-3397-46A8-BB11-6EFF297A72F3 Q35291848-728E3B70-7F51-40AA-B9BB-613C7484F460 Q35480033-9354FCF1-2280-429B-A433-B347C8FC965C

P2860

Laboratory markers in IBD: useful, magic, or unnecessary toys?

http://www.wikidata.org/entity/Q36394876

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Laboratory markers in IBD: useful, magic, or unnecessary toys?

@ast

Laboratory markers in IBD: useful, magic, or unnecessary toys?

@en

type

label

Laboratory markers in IBD: useful, magic, or unnecessary toys?

@ast

Laboratory markers in IBD: useful, magic, or unnecessary toys?

@en

prefLabel

Laboratory markers in IBD: useful, magic, or unnecessary toys?

@ast

Laboratory markers in IBD: useful, magic, or unnecessary toys?

@en

P1433

Q36394876-386746C3-FE7F-4E06-850C-EBB5B48E3270

P1476

Q36394876-5089F273-9FEC-4EEF-987E-12F08899C3C0

P2093

Q36394876-386F52CE-D066-4237-8754-0D20563A7060

Q36394876-852CC753-77EA-4DF0-AD0B-13995C4DFE6E

Q36394876-B987F1B8-B993-40D4-B460-894B92BB809F

P2860

Q36394876-26A25DE8-50ED-4BAA-A3FF-2B462D22488D

Q36394876-28028DDA-8383-4B28-B7F5-65458DE57F78

Q36394876-34466E40-B5E4-4203-86D4-16EC517C0653

Q36394876-3752B622-26A2-4137-A3AC-45FE3EF6EC3A

Q36394876-3B6A7621-E77F-4664-BB84-A57BD0B16CE7

Q36394876-3CB026B1-B0DD-4A5D-A8CF-F8B9232C9E5A

Q36394876-4C6A1EB7-9443-42C9-AED4-168841E15179

Q36394876-5E0FA287-B770-4E7D-8889-9BC98725C366

Q36394876-6695E177-6E77-4D7B-A11C-5A935D6FFBF8

Q36394876-6A6860AE-C50A-4BD0-A411-AE11A15F0453

P304

Q36394876-7FF8686D-9138-4108-8FF2-FC2F9F2C480F

P31

Q36394876-419B5520-1F9F-4C28-812C-E5D4B2140A42

P356

Q36394876-7E9C0F31-3492-4C50-BB34-7D7625503D51

P407

Q36394876-D33130B7-3179-4ECD-AD34-EB09E46D9261

P433

Q36394876-BC4499B8-7840-4A93-B50F-EB9562B3343C

P478

Q36394876-3016E484-58BD-4DA8-8848-9D6116B06816

P577

Q36394876-5BAEFCDC-F784-4567-9FCC-D5304EE953D8

P5875

Q36394876-E841844B-37DA-47D9-9FAC-F685DB4072BA

P698

Q36394876-79918D2C-C727-45B3-A394-165DA221FF4D

P932

Q36394876-6D1D3CE1-686F-4DC4-8606-A68C21B1F504

P356

GUT.2005.069476

P1433

P1476

Laboratory markers in IBD: useful, magic, or unnecessary toys?

@en

P2093

G Van Assche

http://www.w3.org/2001/XMLSchema#string

P Rutgeerts

http://www.w3.org/2001/XMLSchema#string

S Vermeire

http://www.w3.org/2001/XMLSchema#string

P2860

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

A simple method for assessing intestinal inflammation in Crohn's disease

SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS

Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease

A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease

Acute-phase proteins and other systemic responses to inflammation

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

CDP571, a humanised monoclonal antibody to tumour necrosis factor alpha, for moderate to severe Crohn's disease: a randomised, double blind, placebo controlled trial.

Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus.

Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels.

P304

426-431

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.2005.069476

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7302798

http://www.w3.org/2001/XMLSchema#string

P698

16474109

http://www.w3.org/2001/XMLSchema#string

P932

1856093

http://www.w3.org/2001/XMLSchema#string